Navigation Links
Life Sciences Organizations Choose Oracle to Accelerate and Simplify Clinical Trial Data Collection

    REDWOOD SHORES, Calif., Jan. 21 /PRNewswire-FirstCall/ --

    News Facts

-- Organizations spanning the life sciences industry -- including biopharmaceutical companies, contract research organizations (CROs) and pharmaceutical manufacturers -- are increasingly turning to Oracle(R) Remote Data Capture (RDC) 4.5.3 ( conduct trials more efficiently and effectively.

    -- Boehringer Ingelheim, Bristol-Myers
Squibb, ICON, LEO Pharma, PPD
and Quintiles Transnational are among a rapidly
growing group of customers using Oracle RDC 4.5.3 to help increase efficiency
in clinical trials data collection, improve data quality and enhance decision

-- Oracle RDC 4.5.3, the latest release of Oracle's best-in-class electronic data capture (EDC) offering, is completely Web-based -- with zero client footprint for the HTML data entry window -- which enables improved global access and performance.

-- This enables life sciences organizations to conduct global clinical studies more cost effectively using paper, electronic data capture, or hybrid methods.

-- The Oracle EDC application helps meet the needs of trial sponsors as well as investigative site personnel by providing a simplified user interface and eliminating site software installation. This helps to increase staff efficiency by allowing investigators to quickly locate patient visits and case report forms (CRFs).

-- Oracle RDC 4.5.3 is integrated with Oracle Clinical (, the industry's leading clinical data management system, and is an integral component of Oracle's extensive suite of clinical trial management applications.

Supporting Quotes

-- "As one of the largest users of Oracle Remote Data Capture 4.5.3, PPD is providing clients with the robustness and flexibility this system offers. We have realized greater efficiencies since implementing Oracle RDC 4.5.3, including reduced study timelines, real-time decision making and ease of use for investigator sites," said Susan Atkinson, Senior Vice President of Biostatistics and Data Management, PPD.

-- "As a global clinical research organization, we manage clinical trials for the world's top 20 pharmaceutical organizations and leading biotechnology companies. Oracle Remote Data Capture 4.5.3 helps us to accelerate the capture of subject data and offers a robust system of edit checks to ensure the data accuracy and integrity essential to effectively managing global mega trials," said Tom O'Leary, Global Head of Data Management, ICON Clinical Research.

-- "Quintiles Transnational is committed to enhancing clinical trial efficiency for its biotech and pharmaceutical clients worldwide. We looked to Oracle Remote Data Capture to help us rationalize and accelerate the clinical trial process through automated data collection, and more rapid data processing and reporting," said Nicolas Schaltenbrand, Senior Director, Global Data Management, Quintiles Transnational.

-- "Life sciences organizations increasingly require software applications that will help them automate and effectively manage the clinical phase from study setup through submission. Oracle's comprehensive suite of applications for clinical development provides an integrated system for managing large volumes of patient data, as well as sophisticated tracking, analysis and reporting capabilities. Today, hundreds of life sciences organizations are harnessing the power of Oracle's clinical solutions to accelerate insights for better health," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit.

Supporting Resources

    -- Oracle Remote Data Capture Data Sheet

-- Oracle Remote Data Capture 4.5.3 News Release (

    -- Oracle in Health Sciences

-- Oracle Announces Creation of Health Sciences Global Business Unit (

About Oracle

Oracle (Nasdaq: ORCL) is the world's largest enterprise software company. For more information about Oracle, please visit our Web site at


Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.


Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
2. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
3. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
4. Gordon, Familant Join Baker Botts as Part of Expanded Life Sciences IP Initiative
5. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
6. Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
8. Aisling Capital Announces Close of US$650M Life Sciences Fund
9. Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar
10. Cell Biosciences Delivers Next Generation System to Stanford University
11. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... India , November 24, 2015 ... a new market research report "Oligonucleotide Synthesis Market by ... Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, ... 2020", published by MarketsandMarkets, the market is expected to ... Million in 2015, at a CAGR of 10.1% during ...
(Date:11/24/2015)... Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that ... 2015 at 11:00 a.m. Israel time, at the ... Yigal Allon Street, 36 th Floor, Tel Aviv, Israel ... Paneth and Izhak Tamir to the Board of Directors; ... external directors; , approval of an amendment to certain terms of ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:10/29/2015)... Oct. 29, 2015 Daon, a global leader ... has released a new version of its IdentityX ... North America have already installed IdentityX ... includes a FIDO UAF certified server component ... to activate FIDO features. These customers include some of ...
Breaking Biology News(10 mins):